基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 6,452.81
成立日期: 26/01/2004
 
分析
市值分佈:
96.57%
大市值
2.18%
中市值
0.62%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 410  
0%
 
100%
     10大 (51.75%)
代號 名稱 佔比% ▼ 持有日期
PGENPrecigen0.0230/09/2026
AUPHAurinia Pharmaceuticals0.0230/09/2026
NVCRNovoCure Limited0.0230/09/2026
BHVNBiohaven Ltd0.0230/09/2026
INSPInspire Medical Systems0.0230/09/2026
DICETema Trading & Prediction Markets ETF0.0230/06/2023
BFLYButterfly Network0.0230/09/2026
XERSXeris Biopharma Holdings0.0230/09/2026
ALHCAlignment Healthcare0.0230/09/2026
NTLAIntellia Therapeutics0.0230/09/2026
URGNUroGen Pharma Ltd0.0230/09/2026
VRDNViridian Therapeutics0.0230/09/2026
ASTHAstrana Health0.0230/09/2026
NAMSNewAmsterdam Pharma Company NV0.0230/09/2026
BCRXBioCryst Pharmaceuticals0.0230/09/2026
NVAXNovavax0.0230/09/2026
VIRVir Biotechnology0.0230/09/2026
OMCLOmnicell0.0230/09/2026
MLYSMineralys Therapeutics0.0230/09/2026
INVAInnoviva0.0230/09/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.